Notice about cookies

Close

This website uses a limited number of cookies to improve your browsing experience. For further information (including how to withdraw consent), please refer to our Cookie Policy. By clicking Accept below or continuing to use this website (including closing this message), you confirm that you have read and consent to our use of cookies as detailed in our Cookie Policy.

Accept

UCB's Global Corporate Website
Welcome to UCB in the United States

Categories

Archives

Mar

31

Employee Spotlight: Judith Thompson’s Journey to Making a Larger Impact through Addressing Health Disparities for People Living with Severe Diseases

Read More Share:linkedin| twitter| email

Mar

18

Bimekizumab Phase 3 Data in Hidradenitis Suppurativa Show Clinically Meaningful, Deep and Maintained Response over 48 Weeks

Read More Share:linkedin| twitter| email

Mar

17

Exploring the future of dermatology at AAD 2023

Read More Share:linkedin| twitter| email

Mar

16

You Speak, We Listen: How Community Voices Drive Our Work in HS

Read More Share:linkedin| twitter| email

Mar

16

UCB to Present Eight Bimekizumab Abstracts at AAD 2023 with Results from Studies in Psoriasis, Psoriatic Arthritis, and Hidradenitis Suppurativa

Read More Share:linkedin| twitter| email

Mar

15

Building a Community of Trust in Epilepsy & Rare Syndromes

Read More Share:linkedin| twitter| email

© 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
USPR-CORP-0115-00003(2)